[Source: JRC] In a collaborative effort, the JRC and three European partner organisations gathered lacking knowledge necessary to develop predictive in vitro tests that can identify the risk for the development of cumulative dose-dependent cardiotoxicity of cancer patients treated with anthracyclines.
from EUROPA - Syndicated Research News Feed http://ift.tt/2iGv2yj
via IFTTT
No comments:
Post a Comment